Dicot AB

Research Dicot AB (DICOT) on Bullrun: market cap SEK 399.86M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerDICOT
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencySEK
• Market capSEK 399.86M
• Financial periodQ4 2025
• Net income-SEK 16.80M
• Free cash flow-SEK 20.45M

Valuation Snapshot

latest market cap is SEK 399.86M.

About Dicot AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 that is in Phase 2a clinical trial for the treatment of erectile dysfunction and under medical discovery for treating premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.

Frequently asked questions

What is Dicot AB's market cap?

Dicot AB's market capitalization is SEK 399.86M.

What does Dicot AB do?

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 that is in Phase 2a clinical trial for the treatment of erectile dysfunction and under medical discovery for treating premature ejaculation.